Cancers | Free Full-Text | Mucins and Pancreatic Cancer
Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches | Radiation Oncology | Full Text
Translational advances in pancreatic ductal adenocarcinoma therapy | Nature Cancer
Establishment of a pancreatic adenocarcinoma molecular gradient (PAMG) that predicts the clinical outcome of pancreatic cancer - eBioMedicine
Frontiers | Stroma Involvement in Pancreatic Ductal Adenocarcinoma: An Overview Focusing on Extracellular Matrix Proteins
Cells | Free Full-Text | Pancreatic Ductal Adenocarcinoma: Molecular Pathology and Predictive Biomarkers
Frontiers | Pre-clinical Models of Metastasis in Pancreatic Cancer
Cellular and molecular mechanisms of perineural invasion of pancreatic ductal adenocarcinoma - Li - 2021 - Cancer Communications - Wiley Online Library
Soluble AXL is a novel blood marker for early detection of pancreatic ductal adenocarcinoma and differential diagnosis from chronic pancreatitis - eBioMedicine
Expression of novel markers of pancreatic ductal adenocarcinoma in pancreatic nonductal neoplasms: additional evidence of different genetic pathways | Modern Pathology
Genetic progression model of pancreatic carcinogenesis. The main... | Download Scientific Diagram
Molecular biology in pancreatic ductal adenocarcinoma: implications for future diagnostics and therapy | SpringerLink
IJMS | Free Full-Text | Epigenetic Landscape in Pancreatic Ductal Adenocarcinoma: On the Way to Overcoming Drug Resistance?
The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives | Signal Transduction and Targeted Therapy
KRAS wild-type pancreatic ductal adenocarcinoma: molecular pathology and therapeutic opportunities | Journal of Experimental & Clinical Cancer Research | Full Text
High‐grade mesenchymal pancreatic ductal adenocarcinoma drives stromal deactivation through CSF‐1 | EMBO reports
PANCREATIC CANCER :: Molecular pathology of pancreatic diseases
Frontiers | Clinical Impact of Molecular Subtyping of Pancreatic Cancer
Single-cell transcriptomics reveals heterogeneous progression and EGFR activation in pancreatic adenosquamous carcinoma
Frontiers | Deconstructing Pancreatic Cancer Using Next Generation-Omic Technologies–From Discovery to Knowledge-Guided Platforms for Better Patient Management
Microenvironmental Determinants of Pancreatic Cancer | Physiological Reviews
Molecular Events in the Natural History of Pancreatic Cancer: Trends in Cancer
Single-cell analysis of pancreatic ductal adenocarcinoma identifies a novel fibroblast subtype associated with poor prognosis but better immunotherapy response | Cell Discovery
Molecular Pathology and Biomarkers of Pancreatic Ductal Adenocarcinoma | Encyclopedia MDPI
Implementing biological markers as a tool to guide clinical care of patients with pancreatic cancer - ScienceDirect
Frontiers | Cell Lineage Infidelity in PDAC Progression and Therapy Resistance
